INTRODUCTION
In the last three decades hepatobiliary surgery has progressed to become a distinct sub-speciality, with a mortality rate for hepatic resection below 5% 1'2. Hepatectomy may be suitable for primary malignant tumours (hepatocellular carcinoma, cholangiocarcinoma), but in the western world these are outnumbered by liver metastases, 70% of which originate from colorectal primary lesions3. Since most patients with colorectal secondaries are asymptomatic at first, a sensitive test is required to diagnose them early enough for surgical treatment still to be feasible; determination of high levels of carcino-embryonic antigen (CEA) Table 2 shows the number of patients and controls with 'positive' tumour markers.
RESULTS
Of 40 patients with hepatobiliary cancer 18 (45%) had a CA 19-9 level above 46 u/ ml,, 22 (55%) had a CA50 level above 21 u/ml and 15 (48%) had a CEA level above 7/tg/ml. To improve specificity we used multivariant discriminant analysis of the combination of antibodies. The analysis showed a positive result with 53% of the whole malignant group, none of the benign group and 8% of the control group. All three antibodies contributed to the diagnostic accuracy for the whole malignant group (80%) and for secondary tumours (91%) but only CA 19-9 and CA50 contributed to improved diagnostic accuracy in the primary group alone (81%) (Figure 1, Table 4 ). Further breakdown of the primary malignant group shows that CEA was never positive in patients with hepatocellular carcinoma (Table 3) . (n= 14)
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